Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 102, 94-101
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia” (FCT)
- FEDER-COMPETE
This publication has 36 references indexed in Scilit:
- Metformin in early breast cancer: a prospective window of opportunity neoadjuvant studyBreast Cancer Research and Treatment, 2012
- Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast CancersPathology and Oncology Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Metformin Activates AMP Kinase through Inhibition of AMP DeaminaseJournal of Biological Chemistry, 2011
- Metabolic genes in cancer: Their roles in tumor progression and clinical implicationsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Glycolysis inhibition for anticancer treatmentOncogene, 2006
- Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancerJournal of Cellular Physiology, 2004
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976